Alumis, a recent IPO, has ESK-001, a promising phase 3 TYK2 inhibitor for Psoriasis and SLE, showing superior efficacy and safety over existing treatments. ESK-001's allosteric inhibition offers high ...

Urban Heating and Cooling to Play Substantial Role in Future Energy Demand Under Climate Change Sep. 13, 2024 — Existing global energy projections underestimate the impact of climate change on ...

BRIDGEWATER, NJ and LONDON, UK / ACCESSWIRE / September 16, 2024 / Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the ...

The acquisition strengthens the company’s rare disease segment, and adds 2 durable commercial assets, Iluvien and Yutiq with ...

Retail Sales Take on Added Significance as Uncertainty Grows Over Rate Cut Size By Michael Kramer - Sep 17, 2024 2 Today’s retail sales report could be critical, especially if it comes in weak ...

Transaction Will Maximize the Access and Uptake of COSELA® (trilaciclib), the First and Only Proactive Multilineage Myeloprotection Agent -- G1 ...

One year after a rejection by the US Food and Drug Administration (FDA), the UK firm F2G has raised $100 million to push its candidate olorofim to the market for the treatment of rare fungal ...

US retail sales rose strongly in July; up 1.0% versus expected 0.4% gain By Investing.com - Aug 15, 2024 40 Investing.com - U.S. retail sales rose by a larger than expected amount in July ...

Watch the online edition of Global News Hour at 6 BC. Port Moody councillor Haven Lurbiecki said Mayor Meghan Lahti became physical with her during a heated conversation at the event in Toronto ...

Although Black Friday is still the best time to buy almost everything, many other seasonal sales events have become almost as big in recent years. With some retailers still offering Labor Day ...

IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today reported financial results for the first ...